Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buprenorphine 35micrograms/hour transdermal patches
0407020B0AAAEAE
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 6,602 |
|
BuTrans 15micrograms/hour transdermal patches
0407020B0BEADAK
|
BuTrans | Buprenorphine | Central Nervous System | 4,894 |
|
Transtec 52.5micrograms/hour transdermal patches
0407020B0BDABAF
|
Transtec | Buprenorphine | Central Nervous System | 4,418 |
|
Transtec 70micrograms/hour transdermal patches
0407020B0BDACAG
|
Transtec | Buprenorphine | Central Nervous System | 3,313 |
|
Buprenorphine 52.5micrograms/hour transdermal patches
0407020B0AAAFAF
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 3,127 |
|
Buprenorphine 70micrograms/hour transdermal patches
0407020B0AAAGAG
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 1,927 |
|
Bupeaze 35micrograms/hour transdermal patches
0407020B0BIAAAE
|
Bupeaze | Buprenorphine | Central Nervous System | 1,816 |
|
Bupeaze 52.5micrograms/hour transdermal patches
0407020B0BIABAF
|
Bupeaze | Buprenorphine | Central Nervous System | 1,797 |
|
Temgesic 200microgram sublingual tablets
0407020B0BBAAAB
|
Temgesic | Buprenorphine | Central Nervous System | 1,558 |
|
Bupeaze 70micrograms/hour transdermal patches
0407020B0BIACAG
|
Bupeaze | Buprenorphine | Central Nervous System | 1,210 |
|
Rebrikel 5micrograms/hour transdermal patches
0407020B0BVAAAH
|
Rebrikel | Buprenorphine | Central Nervous System | 1,048 |
|
Relevtec 35micrograms/hour transdermal patches
0407020B0BPAAAE
|
Relevtec | Buprenorphine | Central Nervous System | 989 |
|
Rebrikel 20micrograms/hour transdermal patches
0407020B0BVACAJ
|
Rebrikel | Buprenorphine | Central Nervous System | 974 |
|
Rebrikel 10micrograms/hour transdermal patches
0407020B0BVABAI
|
Rebrikel | Buprenorphine | Central Nervous System | 907 |
|
Temgesic 400microgram sublingual tablets
0407020B0BBADAD
|
Temgesic | Buprenorphine | Central Nervous System | 906 |
|
Relevtec 52.5micrograms/hour transdermal patches
0407020B0BPABAF
|
Relevtec | Buprenorphine | Central Nervous System | 616 |
|
Hapoctasin 35micrograms/hour transdermal patches
0407020B0BGAAAE
|
Hapoctasin | Buprenorphine | Central Nervous System | 496 |
|
Buprenorphine 25micrograms/hour transdermal patches
0407020B0AAALAL
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 416 |
|
Relevtec 70micrograms/hour transdermal patches
0407020B0BPACAG
|
Relevtec | Buprenorphine | Central Nervous System | 410 |
|
Hapoctasin 52.5micrograms/hour transdermal patches
0407020B0BGABAF
|
Hapoctasin | Buprenorphine | Central Nervous System | 305 |
|
Panitaz 10micrograms/hour transdermal patches
0407020B0BLABAI
|
Panitaz | Buprenorphine | Central Nervous System | 296 |
|
Hapoctasin 70micrograms/hour transdermal patches
0407020B0BGACAG
|
Hapoctasin | Buprenorphine | Central Nervous System | 289 |
|
Buprenorphine 30micrograms/hour transdermal patches
0407020B0AAAMAM
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 270 |
|
Tephine 200microgram sublingual tablets
0407020B0BFAAAB
|
Tephine | Buprenorphine | Central Nervous System | 231 |
|
Panitaz 20micrograms/hour transdermal patches
0407020B0BLACAJ
|
Panitaz | Buprenorphine | Central Nervous System | 225 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.